期刊文献+

可吸收泪点栓对术前伴干眼症患者LASIK术后的疗效观察 被引量:3

Effect of an absorbable punctal plug in the treatment of preoperative dry eye after laser in situ keratomileusis
原文传递
导出
摘要 目的探讨可吸收泪点栓治疗准分子激光原位角膜磨镶术(LASIK)前伴干眼症患者的效果。方法前瞻性随机双肓对照研究。选取行LASIK术治疗,术前伴轻、中度干眼症的患者41例,同一患者的两眼随机分组,一眼采用可吸收泪点栓结合药物治疗(试验组),另一眼采用单纯药物治疗(对照组)。记录泪点栓的并发症,比较两眼LASIK术前,术后1周和1、3、6个月时泪液分泌试验(SIT)、角膜荧光素染色(FL)、泪膜破裂时间(BUT)和眼表疾病评分(OSDI)的值。运用两相关样本的非参数检验方法(Two Related SamplesTest)进行数据分析。结果除1例患者术后第1天泪点栓脱落外,未见其他并发症。术后1周,试验组的SIT值高于对照组,差异有统计学意义(Z=-2.005,P=0.045),术后1个月及以后,两组的SIT值趋于一致。术后1周、1个月和3个月,试验组的FL值均低于对照组,差异有统计学意义(Z=-2.124、-2.009、-2.120,P〈0.05)。而两组的OSDI和BUT值在上述各时间点差异均没有统计学意义。结论可吸收泪点栓是治疗LASIK术前伴干眼症患者的安全有效的方法。 Objective To evaluate the efficacy of using an absorbable punctal plug in the treatment of preoperative dry eye after laser in situ keratomileusis (LASIK). Methods This was a prospective, randomized, double-blind study. Forty-one consecutive patients with mild to moderate dye eye were included. Absorbable punctal plugs were randomly implanted in one eye of each patient. Fluorescent staining (FL), break-up time (BUT), Sehirmer I test (SIT) and ocular surface disease index (OSDI) grading were performed befbre and 1 week and 1, 3, and 6 months after LASIK. Results No complications were observed except plug extrusion in one ease. FL staining was significantly lower in the treated eyes compared to control eyes at 1 week (Z=-2.124, P=0.034), 1 month (Z=-2.009, P=0.045) and 3 months (Z=-2.120, P=0.034) after LASIK. SIT was significantly higher in the control eyes at 1 week after LASIK (Z=-2.005, P=0.045). Conclusion An absorbable punctal plug is an effective method for treating dry eye patients after LASIK.
出处 《中华眼视光学与视觉科学杂志》 CAS 2012年第4期208-211,共4页 Chinese Journal Of Optometry Ophthalmology And Visual Science
关键词 角膜磨镶术 激光原位 干眼病 泪点栓 治疗结果 对照研究 Keratomileusis,laser in situ Xerophthalmia Punetal plug Treatment outcome Comparative study
  • 相关文献

参考文献19

  • 1王华,刘祖国,彭娟,林辉,钟敬祥,胡皎月.环戊硫酮治疗干眼的临床疗效评价[J].中华眼科杂志,2009,45(6):492-497. 被引量:27
  • 2Quinto GG, Camacho W, Behrens A. Postrefractive surgery dry eye. Curr Opin Ophthalmol,2008,19:335-341.
  • 3Schallhorn SC, Amesbury EC, Tanzer DJ. Avoidance, recognition, and management of LASIK complications. Am J Ophthalmol, 2006,141:733-739.
  • 4Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea, 2006,25 : 900-907.
  • 5Baxter SA, Laibson PR. Punctal plugs in the management of dry eyes. Ocul Surf,2004,2:255-265.
  • 6Albietz JM, Lenton LM. Management of the ocular surface and tear film before, during, and after laser in situ keratomilensis. J Refract Surg,2004,20:62-71.
  • 7刘祖国.干眼的诊断[J].中华眼科杂志,2002,38(5):318-320. 被引量:345
  • 8刘祖国,彭娟.干眼的诊断与治疗规范[J].眼科研究,2008,26(3):161-164. 被引量:282
  • 9Toda I. LASIK and the ocular surface. Comea,2008,27(Suppll): S70-76.
  • 10De Paiva CS, Chen Z, Koch DD, et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol, 2006,141:438-445.

二级参考文献31

  • 1李莹,刘淑玲,王忠海,金玉梅,孙玉敏.硅泪小管塞在不同干眼症治疗中的应用[J].中国实用眼科杂志,2004,22(9):715-718. 被引量:22
  • 2张汗承,周祖廉,赵成荣,李燕先.干眼病记分分级和人工泪疗效评价的研究[J].眼科研究,1994,12(1):25-28. 被引量:119
  • 3陈问京,张污承.我国正常人和若干眼病中泪液乳铁蛋白的变化规律[J].中华眼科杂志,1989,25(5):292-295. 被引量:29
  • 4Nagano T,Takeyama M.Enhancement of salivary secretion and neuropeptide (substance P,alpha-calcitonin gene-related peptide) levels in saliva by chronic anethole trithione treatment.J Pharm Pharmacol,2001,53:1697-1702.
  • 5Jing Q,Shen Y,Ren F,et al.HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits.J Pharm Biomed Anal,2006,42:613-617.
  • 6Perry HD,Solomon R,Donnenfeld ED,et al.Evaluation of topical cyclosporine for the treatment of dry eye disease.Arch Ophthalmol,2008,126:1046-1050.
  • 7Johnson ME,Murphy PJ,Boulton M.Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.Optom Vis Sci,2008,85:750-757.
  • 8Kaido M,Ishida R,Dogru M,et al.Efficacy of puncture plug treatment in short break-up time dry eye.Optom Vis Sci,2008,85:758-763.
  • 9Latkany R.Dry eyes:etiology and management.Curt Opin Ophthalmol,2008,19:287-291.
  • 10Hamada T,Nakane T,Kimura T,et al.Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione:a clinical trial.Am J Med Sci,1999,318:146-151.

共引文献615

同被引文献43

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部